NASDAQ:AGTC
Delisted
Applied Genetic Technologies Corporation Stock News
$0.397
+0 (+0%)
At Close: Feb 28, 2023
Analysts Offer Insights on Healthcare Companies: Karuna Therapeutics (NASDAQ: KRTX) and aTyr Pharma (NASDAQ: LIFE) - Markets
10:21am, Wednesday, 24'th Jun 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Karuna Therapeutics (KRTX – Research
Applied Genetic Technologies (NASDAQ:AGTC) Coverage Initiated at Cantor Fitzgerald
01:54am, Wednesday, 24'th Jun 2020
Stock analysts at Cantor Fitzgerald assumed coverage on shares of Applied Genetic Technologies (NASDAQ:AGTC) in a report issued on Monday, Marketbeat reports. The brokerage set an “overweight” rat
H.C. Wainwright Thinks Palatin Technologies' Stock is Going to Recover - Markets
01:44pm, Tuesday, 23'rd Jun 2020
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Palatin Technologies (PTN – Research Report) today and set a
H.C. Wainwright Reaffirms Their Buy Rating on ESSA Pharma (EPIX) - Markets
10:16am, Tuesday, 23'rd Jun 2020
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on ESSA Pharma (EPIX – Research
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Karyopharm Therapeutics
Lineage Cell Therapeutics (LCTX) Gets a Buy Rating from H.C. Wainwright - Markets
11:33am, Monday, 22'nd Jun 2020
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Lineage Cell Therapeutics (LCTX – Research Report) on June 18
AGTC Announces Significant Productivity and Quality Enhancement To Its Proprietary Manufacturing Process
11:00am, Monday, 22'nd Jun 2020
Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today
Financial Analysis: INmune Bio (NASDAQ:INMB) and Applied Genetic Technologies (NASDAQ:AGTC)
01:48am, Friday, 19'th Jun 2020
INmune Bio (NASDAQ:INMB) and Applied Genetic Technologies (NASDAQ:AGTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the stre
US Patent Office Grants Key Risk Test Patent | MarketScreener
12:01pm, Thursday, 18'th Jun 2020Dow Jones Today Rising After the Latest Statement from Federal Reserve Chair
02:18pm, Wednesday, 17'th Jun 2020
The Dow Jones today is climbing on continued optimism that the Federal Reserve's latest policy can protect the economy from a crash. How certain are they?
H.C. Wainwright Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP) - Markets
12:58pm, Wednesday, 17'th Jun 2020
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Armata Pharmaceuticals (ARMP – Research Report) today and set a
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:27am, Wednesday, 17'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenetic Biosciences
AGTC to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on June 23, 2020
08:01pm, Tuesday, 16'th Jun 2020
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 16, 2020 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
Bionic Sight, LLC announced today that it has dosed the first patient in the Company’s Phase 1/2 clinical trial of BS01, an optogenetic gene therapy for patients with Retinitis Pigmentosa. This is
Atreca (BCEL) Receives a Rating Update from a Top Analyst - Markets
10:14am, Tuesday, 16'th Jun 2020
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Atreca (BCEL – Research Report),
